Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)	Plaque Psoriasis	Recruiting	Phase 3	2026-09-22		NCT07116967

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bristol-Myers Squibb	422

314 results · Page 1 of 13

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aalborg Universitetshospital	Aalborg	Denmark	19
Aarhus University Hospital	Aarhus	Denmark	95
Accellacare - Cary	Cary	United States	3
Advanced Dermatology and Skin Cancer Institute - Beverly Hills	Sherman Oaks	United States	1
Affiliated Hospital of Jiangsu University	Zhenjiang	China	2
Ai Centrum Medyczne	Poznan	Poland	1
Alberta DermaSurgery Centre	Edmonton	Canada	8
Allergo-Derm Kft	Szolnok	Hungary	1
Alliance Dermatology	Phoenix	United States	3
Apex Clinical Research Center	Mayfield Heights	United States	6
Apex Clinical Research Center - Canton	Canton	United States	3
Arlington Center for Dermatology	Arlington	United States	3
Avenue Research Group	Toronto	Canada	2
Azienda Ospedaliero-Universitaria di Modena - Policlinico di Modena	Baggiovara	Italy	3
Barts Health NHS Trust	London	United Kingdom	1
Beacon Dermatology	Calgary	Canada	2
Beijing Friendship Hospital,Capital Medical University	Beijing	China	3
Beijing Tongren Hospital West	Beijing	China	1
Best Skin Research	Camp Hill	United States	1
BioResearch Partner (BRP) - Miami	Miami	United States	1
Bispebjerg Hospital	Copenhagen	Denmark	5
Buenos Aires Skin S.A	Buenos Aires	Argentina	1
C.M.D.T.A. Neomed SRL	Brasov	Romania	1
Cabinet Dermatologie Lauderma	Iași	Romania	1
California Dermatology & Clinical Research Institute	Encinitas	United States	13

Clinical trials